ABIVAX SA AMERICAN DEPOSITARY SHARES reports a Return on Equity (ROE) of -125.22%.

What is ABVX's dividend yield?

ABIVAX SA AMERICAN DEPOSITARY SHARES offers a dividend yield of 0.00%.

What is ABVX's Deepscope Quality Score?

Deepscope rates ABVX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ABVX?

Deepscope's AI Timing Score for ABVX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ABVX belong to?

ABIVAX SA AMERICAN DEPOSITARY SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

ABVX (NASDAQ) 株価分析 | ABIVAX SA AMERICAN DEPOSITARY SHARES

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

ABVX

ABIVAX SA AMERICAN DEPOSITARY SHARES

US:NASDAQ STOCK Healthcare >> Biotechnology News 71

USD 90.15

17.65 (24.34%) Day Change

Watchlist Portfolio Compare Chart

0.27

D/E

-125.2%

ROE

-98.3%

ROA

0.00%

Div Yield

ABIVAX SA AMERICAN DEPOSITARY SHARES
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 90.15 Price 17.65 (24.34%) Day Change	NEWS SCORE: 71

ABVX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	71
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	90.15
PBV / Sector	13.45 / 4.48
Earning Per Share	-8.39

PE / Sector	N/A / 16.68
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	211.91 M GREAT
Average 1W Daily Value	474.43 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.37
NPM Average (%) / Sector	-2,051.85 / -1,506.30
NPM Change Average (%) / Sector	N/A / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-98.32 / 30.83
ROA Average (%) / Sector	-73.46 / -347.12
ROA Change Average (%) / Sector	21.04 / 5,126.35 GREAT
ROE (%) / Sector	-125.22 / -3.04
ROE Average (%) / Sector	-310.73 / 40.76
ROE Change Average (%) / Sector	92.90 / 2,110.63 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

登録情報

Analyze Date	2026-06-04 09:23:57
Symbol	ABVX
Name	ABIVAX SA AMERICAN DEPOSITARY SHARES
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	79.69 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5,777.85 / 8,483.11

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 7-11 Boulevard Haussmann, Paris, France, 75009

Phone: 33 1 53 83 09 63

Website: https://www.abivax.com

Employees: 80

Sector: Healthcare >> Biotechnology

Description: ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.